Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Postoperative Nausea and Vomiting × Aprepitant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 38 Nausea 28 Breast Neoplasms 10 Neoplasms 9 Lymphoma 8 Multiple Myeloma 6 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Carcinoma, Non-Small-Cell Lung 4 Sezary Syndrome 3 Pruritus 3 Myeloproliferative Disorders 3 Leukemia 3 Gastrointestinal Neoplasms 3 Testicular Neoplasms 2 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pdgfra-Associated Chronic Eosinophilic Leukemia 2 Neuroblastoma 2 Neoplasms, Plasma Cell 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Neutrophilic, Chronic 2

Interventions

Dexamethasone 4 ramosetron 3 Ondansetron 2 Calcium Dobesilate 2 Acupuncture Therapy 2 phenazine 1 esmolol 1 Therapeutics 1 Surveys and Questionnaires 1 Sufentanil 1 Promethazine 1 Postoperative Care 1 Olanzapine 1 Gelatin 1 Fentanyl 1 Famotidine 1 Electric Stimulation Therapy 1 Electric Stimulation 1 Diphenhydramine 1 Dexmedetomidine 1 Aprepitant 1 Antiemetics 1 Anesthesia, General 1 Anesthesia 1 Analgesics, Opioid 1 Adrenergic beta-Antagonists 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01046461 2012-02-17

RAD

Hallym University Medical Center

Phase 2 Unknown

Nausea, Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡